Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series D brings in $10mm for Kona Medical

Executive Summary

Morningside Group was the sole investor in Kona Medical Inc.’s $10mm Series D venture round. The funds will be used to market Kona’s Surround Sound renal denervation system in China. The product uses ultrasound to treat nerves leading to and from the kidney, ultimately lowering blood pressure in drug-resistant hypertension patients.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies